Prescription drug · ANDA
Methylprednisolone Sodium Succinate NDC 51662-1695
Methylprednisolone sodium succinate 125 mg/2mL · Injection · Intravascular, Intravenous · HF Acquisition Co LLC, DBA HealthFirst
NDC codes
FDA NDC DirectoryProduct information
- Brand name (proprietary)
- Methylprednisolone Sodium Succinate
- Generic name (nonproprietary)
- methylprednisolone sodium succinate
- Active ingredients
- Methylprednisolone sodium succinate — 125 mg/2mL
- Dosage form
- Injection
- Route
- Intravascular, Intravenous
- Labeler
- HF Acquisition Co LLC, DBA HealthFirstNDC labeler code 51662
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 212396
- Marketing start
- Listing expires
- Other FDA classes
- Corticosteroid Hormone Receptor Agonists (Mechanism)
- Identifiers
- Product ID 51662-1695_575f4901-bec6-37d8-e063-6394a90a060bSPL ID 575f4901-bec6-37d8-e063-6394a90a060bSPL set ID 559427ac-9fc6-96f5-e063-6294a90a0b30RxCUI 1743704UNII LEC9GKY20KUPC 0343598129013
- Pharmacologic class
- Corticosteroid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
When oral therapy is not feasible, and the strength, dosage form and route of administration of the drug reasonably lend the preparation to the treatment of the condition, theintravenous or intramuscular use of methylprednisolone sodium succinate for injection, USP is indicated as follows: Allergic states: Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, serum sickness, transfusion reactions. Dermatologic diseases: Bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multiforme (Stevens-Johnson …
Excerpt only. Read the full label for complete information.
About NDC 51662-1695
- What is NDC 51662-1695?
- 51662-1695 is the product NDC for Methylprednisolone Sodium Succinate, Methylprednisolone sodium succinate 125 mg/2mL injection, listed with the FDA by HF Acquisition Co LLC, DBA HealthFirst.
- What drug is associated with this NDC?
- Methylprednisolone Sodium Succinate.
- What is the active ingredient?
- Methylprednisolone sodium succinate.
- Who is the labeler?
- HF Acquisition Co LLC, DBA HealthFirst, NDC labeler code 51662. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Methylprednisolone Sodium Succinate?
- 27 other product NDCs are listed under this name. See all Methylprednisolone Sodium Succinate NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Methylprednisolone Sodium Succinate products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Methylprednisolone Sodium Succinate | Methylprednisolone sodium succinate 40 mg/1 | Injection, Powder, For solutionIntramuscular, Intravenous | Civica, Inc. | 72572-097 | 72572-0097-25 |
| Methylprednisolone Sodium Succinate | Methylprednisolone sodium succinate 125 mg/1 | Injection, Powder, For solutionIntramuscular, Intravenous | Civica, Inc. | 72572-098 | 72572-0098-25 |
| Methylprednisolone Sodium Succinate | Methylprednisolone sodium succinate 125 mg/1 | Injection, Powder, For solutionIntramuscular, Intravenous | REMEDYREPACK INC. | 70518-4345 | 70518-4345-00 |
| Methylprednisolone Sodium Succinate | Methylprednisolone sodium succinate 1 g/1 | Injection, Powder, For solutionIntramuscular, Intravenous | Hikma Pharmaceuticals USA Inc. | 0143-9182 | 00143-9182-01 |
| Methylprednisolone sodium succinate | Methylprednisolone sodium succinate 125 mg/2mL | InjectionIntramuscular, Intravenous | REMEDYREPACK INC. | 70518-3684 | 70518-3684-00 |
| Methylprednisolone Sodium Succinate | Methylprednisolone sodium succinate 40 mg/1 | Injection, Powder, For solutionIntramuscular, Intravenous | Hikma Pharmaceuticals USA Inc. | 0143-9753 | 00143-9753-25 |
| Methylprednisolone Sodium Succinate | Methylprednisolone sodium succinate 125 mg/1 | Injection, Powder, For solutionIntramuscular, Intravenous | Hikma Pharmaceuticals USA Inc. | 0143-9754 | 00143-9754-25 |
| Methylprednisolone sodium succinate | Methylprednisolone sodium succinate 40 mg/mL | InjectionIntramuscular, Intravenous | Dr. Reddy's Laboratories Inc | 43598-127 | 43598-0127-25 |
| Methylprednisolone sodium succinate | Methylprednisolone sodium succinate 1 g/16mL | InjectionIntramuscular, Intravenous | Dr. Reddy's Laboratories Inc | 43598-130 | 43598-0130-74 |
| Methylprednisolone sodium succinate | Methylprednisolone sodium succinate 500 mg/8mL | InjectionIntramuscular, Intravenous | Dr. Reddy's Laboratories Inc | 43598-128 | 43598-0128-11 |
Other NDCs under ANDA 212396
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Methylprednisolone sodium succinate | Methylprednisolone sodium succinate 40 mg/mL | InjectionIntramuscular, Intravenous | Dr. Reddy's Laboratories Inc | 43598-127 |
| Methylprednisolone sodium succinate | Methylprednisolone sodium succinate 500 mg/8mL | InjectionIntramuscular, Intravenous | Dr. Reddy's Laboratories Inc | 43598-128 |
| Methylprednisolone sodium succinate | Methylprednisolone sodium succinate 125 mg/2mL | InjectionIntramuscular, Intravenous | Dr. Reddy's Laboratories Inc | 43598-129 |
| Methylprednisolone sodium succinate | Methylprednisolone sodium succinate 1 g/16mL | InjectionIntramuscular, Intravenous | Dr. Reddy's Laboratories Inc | 43598-130 |
| Methylprednisolone sodium succinate | Methylprednisolone sodium succinate 125 mg/2mL | InjectionIntramuscular, Intravenous | REMEDYREPACK INC. | 70518-3684 |
| Methylprednisolone Sodium Succinatemethylprednisolone | Methylprednisolone sodium succinate 40 mg/mL | Injection, Powder, Lyophilized, For solutionIntramuscular, Intravenous | Tianjin Kingyork Pharmaceuticals Co., Ltd | 82094-401 |
| Methylprednisolone Sodium Succinatemethylprednisolone | Methylprednisolone sodium succinate 125 mg/2mL | Injection, Powder, Lyophilized, For solutionIntramuscular, Intravenous | Tianjin Kingyork Pharmaceuticals Co., Ltd | 82094-402 |
| Methylprednisolone Sodium Succinatemethylprednisolone | Methylprednisolone sodium succinate 500 mg/8mL | Injection, Powder, Lyophilized, For solutionIntramuscular, Intravenous | Tianjin Kingyork Pharmaceuticals Co., Ltd | 82094-403 |
| Methylprednisolone Sodium Succinatemethylprednisolone | Methylprednisolone sodium succinate 1 g/16mL | Injection, Powder, Lyophilized, For solutionIntramuscular, Intravenous | Tianjin Kingyork Pharmaceuticals Co., Ltd | 82094-404 |
| Methylprednisolone Sodium Succinatemethylprednisolone | Methylprednisolone sodium succinate 2 g/30.6mL | Injection, Powder, Lyophilized, For solutionIntramuscular, Intravenous | Tianjin Kingyork Pharmaceuticals Co., Ltd | 82094-405 |